Richard Zelman

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 638 citations · Full text

Medicine, Cardiology, Surgery +14

Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

Gregg W. Stone, Michel E. Bertrand, Jeffrey W. Moses et al. · JAMA · 2007 · 302 citations

Medicine, Cardiology, Internal Medicine +16

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 57 citations

Medicine, Cardiology, Pharmacology +14

Feasibility study of the RenalGuard™ balanced hydration system: A novel strategy for the prevention of contrast-induced nephropathy in high risk patients

Jean-François Dorval, Simon Dixon, Richard Zelman et al. · International Journal of Cardiology · 2011 · 45 citations

Medicine, Nephrology, Renal Pathophysiology +14

Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention

Shigetaka Kageyama, Patrick W. Serruys, Kai Ninomiya et al. · European Journal of Cardio-Thoracic Surgery · 2023 · 12 citations · Full text

Medicine, Cardiology, Surgery +15